HK1106550A1 - Identification marker responsive to interferon therapy for renal cell cancer - Google Patents

Identification marker responsive to interferon therapy for renal cell cancer

Info

Publication number
HK1106550A1
HK1106550A1 HK07111969.7A HK07111969A HK1106550A1 HK 1106550 A1 HK1106550 A1 HK 1106550A1 HK 07111969 A HK07111969 A HK 07111969A HK 1106550 A1 HK1106550 A1 HK 1106550A1
Authority
HK
Hong Kong
Prior art keywords
renal cell
cell cancer
identification marker
interferon therapy
marker responsive
Prior art date
Application number
HK07111969.7A
Other languages
English (en)
Inventor
Toyokazu Seki
Takayuki Shiratsuchi
Osamu Ogawa
Seiji Naito
Taiji Tsukamoto
Hiroshi Toma
Yoshihiko Hirao
Susumu Kagawa
Yoshiaki Nose
Tsuyoshi Nakamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1106550A1 publication Critical patent/HK1106550A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
HK07111969.7A 2004-10-28 2007-11-05 Identification marker responsive to interferon therapy for renal cell cancer HK1106550A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004314160 2004-10-28
PCT/JP2005/019491 WO2006046505A1 (ja) 2004-10-28 2005-10-24 腎細胞癌に対するインターフェロン治療反応性識別マーカー

Publications (1)

Publication Number Publication Date
HK1106550A1 true HK1106550A1 (en) 2008-03-14

Family

ID=36227744

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07111969.7A HK1106550A1 (en) 2004-10-28 2007-11-05 Identification marker responsive to interferon therapy for renal cell cancer

Country Status (8)

Country Link
US (1) US7838229B2 (ja)
EP (3) EP2453015A1 (ja)
JP (2) JP5078358B2 (ja)
CN (3) CN101048504B (ja)
CA (1) CA2585244C (ja)
ES (1) ES2364157T3 (ja)
HK (1) HK1106550A1 (ja)
WO (1) WO2006046505A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5041580B2 (ja) * 2006-10-17 2012-10-03 一般財団法人化学及血清療法研究所 仲介ポリヌクレオチド
WO2013056396A1 (zh) * 2011-10-19 2013-04-25 深圳华大基因科技有限公司 用于肾癌诊断评估的序列、使用方法及其应用
JP2013180090A (ja) 2012-03-02 2013-09-12 Gc Corp 下顎用の印象用トレー
JP5876356B2 (ja) 2012-03-30 2016-03-02 株式会社ジーシー 局部用印象用トレー
JP5778611B2 (ja) 2012-03-30 2015-09-16 株式会社ジーシー 上顎用の印象用トレー

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2825976A (en) 1956-05-28 1958-03-11 Frank J Radencic Repeat apparatus for holding negatives used in lithography
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
WO1998023774A1 (en) 1996-11-29 1998-06-04 Third Wave Technologies, Inc. Fen-1 endonucleases, mixtures and cleavage methods
US6159693A (en) 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
JP2000279197A (ja) 1999-03-31 2000-10-10 Genome Science Laboratories Co Ltd Ｈｉｖの変異の検出方法
JP2001136973A (ja) 1999-11-16 2001-05-22 Otsuka Pharmaceut Co Ltd Ｉｒｆ−１遺伝子異常の検出方法
US20030096237A1 (en) 2000-08-28 2003-05-22 Ulrich Certa Determination of the ability of patients to respond to a tumor treatment
JP2002125683A (ja) * 2000-10-27 2002-05-08 Tokyoto Igaku Kenkyu Kiko インターフェロンの有効性を予測する方法並びにそれに用いられるプライマー及びプローブ
JP3751867B2 (ja) 2001-09-18 2006-03-01 株式会社東芝 インターフェロンを投与されるべき個体においてインターフェロン療法の有効性を予測する方法、その方法をコンピュータにより実行させるためのプログラム、インターフェロン感受性に関連する多型部位の遺伝子型を検出するための核酸プローブ、およびその核酸プローブを具備する塩基配列検出用チップ
EP1375672A4 (en) 2001-03-27 2005-02-16 Toshiba Kk METHOD FOR DETECTING NUCLEIC ACID RELATING TO A DISEASE
JP4295955B2 (ja) 2002-05-24 2009-07-15 株式会社東芝 インターフェロンαレセプター２型遺伝子の多型およびその使用
WO2004033650A2 (en) * 2002-10-08 2004-04-22 The Brigham And Women's Hospital, Inc. Diagnostic assay and related products

Also Published As

Publication number Publication date
US20080199859A1 (en) 2008-08-21
CN101684501A (zh) 2010-03-31
US7838229B2 (en) 2010-11-23
EP2354228A3 (en) 2011-11-02
CN101048504B (zh) 2011-06-29
CA2585244C (en) 2015-02-17
ES2364157T3 (es) 2011-08-26
CN101048504A (zh) 2007-10-03
EP2354228A2 (en) 2011-08-10
CA2585244A1 (en) 2006-05-04
JP5078358B2 (ja) 2012-11-21
EP1813673A4 (en) 2009-07-15
EP1813673A1 (en) 2007-08-01
WO2006046505A1 (ja) 2006-05-04
EP1813673B1 (en) 2011-05-11
JP2011217753A (ja) 2011-11-04
JPWO2006046505A1 (ja) 2008-05-22
EP2453015A1 (en) 2012-05-16
EP2354228A8 (en) 2012-03-14
CN102242196A (zh) 2011-11-16

Similar Documents

Publication Publication Date Title
EP1749095A4 (en) NEW THERAPEUTIC TARGETS IN CANCER
EP1909832A4 (en) ANTIBODY IMMUNOCELL LIGAND FUSION PROTEIN FOR CANCER THERAPY
IL227562A (en) Symptoms of breast cancer
PL1766017T3 (pl) Przeciwciało specyficzne wobec nowotworu
PL1720611T3 (pl) Marker diagnostyczny dla raka
DE502005008820D1 (en) Turbo-compound system
PL2573166T3 (pl) Sposoby otrzymywania komórek T do terapii komórkowej
AU2003235470A8 (en) Predictive markers in cancer therapy
EP1994411A4 (en) SHORTENED PROTEINS AS CANCER MARKERS
EP2135243A4 (en) PLAYLISTS RESPONSING TO COINCIDENCE DISTANCES
EP1802764A4 (en) BIOLOGICAL MARKERS FOR BREAST CANCER
EP2139913A4 (en) INDUCTION OF TUMOR CELL DEATH THROUGH IMMUNE
EP1793678A4 (en) TUMOR TREATMENT BY INJECTION OF DENDRITIC CELLS
HK1106550A1 (en) Identification marker responsive to interferon therapy for renal cell cancer
EP1757686A4 (en) INDUCER OF CELL DEATH
GB0421838D0 (en) Cancer markers
AU304007S (en) Dress-making line marker
EP1778873A4 (en) NEW THERAPEUTIC TARGETS AGAINST CANCER
GB2430376B (en) Electromagnetic delivery system to influence a biological system
PL1743035T3 (pl) Sposób wykrywania predyspozycji do nowotworów
GB0416830D0 (en) Host cell
EP1625853A4 (en) APOPTOSIS INDUCER FOR CANCER CELL
GB0428505D0 (en) Distance marker
EP1931795A4 (en) CELL DIVISION MARKER
EP1716167A4 (en) CELL SURFACE MARKER

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151024